CTSB and atherosclerosis: applied the cathepsin B‐sensitive NIRF probe (with the same structure as just described[9]) in murine model to determine the potential of atherosclerosis associated activation of the cathepsin B‐sensitive probe using fluorescence‐mediated tomography (FMT).